A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01312389 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Did not meet criteria laid out in Phase 1 to continue to Phase 2

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: OC-L/Montanide ISA 51 VG
BIOLOGICAL: Ampligen
BIOLOGICAL: Prevnar

Sponsor

Abramson Cancer Center at Penn Medicine